Screener
Surgery Partners, Inc. SGRY EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Surgery Partners, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001638833-26-000046
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Less: Net income attributable to non-controlling interests | (33.8) | (37.4) |
| Net income (loss) attributable to Surgery Partners, Inc. | $(35.9) | $(37.7) |
| Net loss per share attributable to common stockholders: | ||
| Basic | $(0.28) | $(0.30) |
| Diluted (1) | $(0.28) | $(0.30) |
| Weighted average common shares outstanding: | ||
| Basic | 128,367 | 126,602 |
| Diluted (1) | 128,367 | 126,602 |
Item 1. Financial Statements
FAQ
- What is Surgery Partners, Inc.'s EPS (diluted)?
- Surgery Partners, Inc. (SGRY) reported EPS (diluted) of -$0.28 in Q1 2026.
- How has Surgery Partners, Inc.'s EPS (diluted) changed year-over-year?
- Surgery Partners, Inc.'s EPS (diluted) increased by 6.7% year-over-year, from -$0.30 to -$0.28.
- What is the long-term trend for Surgery Partners, Inc.'s EPS (diluted)?
- Over 3 years (2022 to 2025), Surgery Partners, Inc.'s EPS (diluted) has grown at a 1.1% compound annual growth rate (CAGR), from -$0.59 to -$0.61.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Surgery Partners, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude